Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| IgA Deficiency | 2 | 2018 | 36 | 0.91 | Why? |
| Immunoglobulin A | 4 | 2021 | 3567 | 0.84 | Why? |
| Immunoglobulin A, Secretory | 1 | 2018 | 56 | 0.77 | Why? |
| Chickenpox | 1 | 2017 | 194 | 0.52 | Why? |
| Herpes Zoster | 1 | 2017 | 331 | 0.45 | Why? |
| Platelet Factor 4 | 1 | 2014 | 385 | 0.42 | Why? |
| Interferon Type I | 5 | 2021 | 2789 | 0.36 | Why? |
| T-Lymphocytes, Helper-Inducer | 1 | 2011 | 497 | 0.35 | Why? |
| Scleroderma, Systemic | 1 | 2014 | 583 | 0.34 | Why? |
| Immunotherapy | 1 | 2020 | 2421 | 0.32 | Why? |
| Dendritic Cells | 2 | 2017 | 1330 | 0.31 | Why? |
| Immunity, Humoral | 1 | 2020 | 4849 | 0.30 | Why? |
| Autoantibodies | 3 | 2021 | 2094 | 0.29 | Why? |
| Gastrointestinal Microbiome | 1 | 2018 | 1961 | 0.29 | Why? |
| Cytokines | 3 | 2021 | 15010 | 0.27 | Why? |
| Dermatitis, Atopic | 1 | 2011 | 714 | 0.25 | Why? |
| Antibodies, Monoclonal | 2 | 2020 | 8041 | 0.23 | Why? |
| CD8 Antigens | 1 | 2021 | 72 | 0.23 | Why? |
| Receptors, CXCR3 | 1 | 2021 | 159 | 0.22 | Why? |
| Antibodies, Neutralizing | 5 | 2021 | 25288 | 0.21 | Why? |
| Immunoglobulin G | 4 | 2021 | 21571 | 0.20 | Why? |
| Loss of Function Mutation | 1 | 2020 | 244 | 0.18 | Why? |
| HIV Envelope Protein gp41 | 1 | 2019 | 153 | 0.17 | Why? |
| Interferon beta-1a | 1 | 2021 | 316 | 0.17 | Why? |
| Organ Preservation Solutions | 1 | 2017 | 20 | 0.17 | Why? |
| B7-H1 Antigen | 1 | 2021 | 541 | 0.17 | Why? |
| Plasmapheresis | 1 | 2021 | 437 | 0.17 | Why? |
| Extraembryonic Membranes | 1 | 2016 | 19 | 0.17 | Why? |
| Erdheim-Chester Disease | 1 | 2017 | 50 | 0.17 | Why? |
| Psoriasis | 1 | 2011 | 1739 | 0.17 | Why? |
| Histiocytosis, Langerhans-Cell | 1 | 2017 | 46 | 0.17 | Why? |
| Common Variable Immunodeficiency | 1 | 2018 | 195 | 0.15 | Why? |
| Bone Marrow Cells | 1 | 2017 | 186 | 0.15 | Why? |
| Proto-Oncogene Proteins B-raf | 1 | 2017 | 179 | 0.15 | Why? |
| Respiration, Artificial | 1 | 2021 | 22116 | 0.15 | Why? |
| Proto-Oncogene Proteins | 1 | 2017 | 340 | 0.14 | Why? |
| Herpesvirus 3, Human | 1 | 2017 | 228 | 0.14 | Why? |
| Antibodies, Bacterial | 1 | 2018 | 510 | 0.14 | Why? |
| Hematopoietic Stem Cells | 1 | 2017 | 321 | 0.14 | Why? |
| Latent Tuberculosis | 1 | 2018 | 324 | 0.14 | Why? |
| DNA-Binding Proteins | 1 | 2017 | 469 | 0.13 | Why? |
| Epitope Mapping | 1 | 2019 | 1240 | 0.13 | Why? |
| Labor, Obstetric | 1 | 2016 | 257 | 0.13 | Why? |
| Plasma Exchange | 1 | 2021 | 763 | 0.13 | Why? |
| Antineoplastic Agents, Immunological | 1 | 2020 | 830 | 0.13 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.12 | Why? |
| HIV Antibodies | 1 | 2019 | 776 | 0.12 | Why? |
| Peptide Library | 1 | 2015 | 564 | 0.12 | Why? |
| Immunoglobulin M | 2 | 2020 | 9091 | 0.11 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2020 | 2309 | 0.11 | Why? |
| Receptors, Antigen, T-Cell | 1 | 2017 | 760 | 0.11 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.11 | Why? |
| Host-Pathogen Interactions | 2 | 2020 | 11041 | 0.10 | Why? |
| Chemokines | 1 | 2015 | 1095 | 0.10 | Why? |
| Lymphopenia | 1 | 2021 | 2669 | 0.09 | Why? |
| Interferon-gamma | 1 | 2018 | 2711 | 0.09 | Why? |
| Immunity, Cellular | 1 | 2021 | 3614 | 0.09 | Why? |
| Humans | 24 | 2021 | 930598 | 0.09 | Why? |
| Microbiota | 1 | 2018 | 1240 | 0.09 | Why? |
| Case-Control Studies | 3 | 2021 | 17671 | 0.09 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.08 | Why? |
| Epitopes | 1 | 2019 | 4113 | 0.08 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2021 | 4545 | 0.08 | Why? |
| Lopinavir | 1 | 2021 | 4308 | 0.08 | Why? |
| Ritonavir | 1 | 2021 | 4212 | 0.08 | Why? |
| Mice | 3 | 2020 | 21357 | 0.08 | Why? |
| Longitudinal Studies | 1 | 2020 | 9893 | 0.07 | Why? |
| Time Factors | 4 | 2021 | 31397 | 0.07 | Why? |
| Feces | 1 | 2018 | 4235 | 0.07 | Why? |
| Virus Shedding | 1 | 2021 | 5834 | 0.07 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2021 | 5837 | 0.07 | Why? |
| Saliva | 1 | 2020 | 4679 | 0.07 | Why? |
| Alleles | 2 | 2020 | 1557 | 0.06 | Why? |
| Immunoassay | 1 | 2018 | 4485 | 0.06 | Why? |
| Extracorporeal Membrane Oxygenation | 1 | 2021 | 5002 | 0.06 | Why? |
| Neoplasms | 2 | 2021 | 17251 | 0.06 | Why? |
| Micrococcaceae | 1 | 2021 | 72 | 0.06 | Why? |
| Anti-Inflammatory Agents | 1 | 2020 | 6153 | 0.05 | Why? |
| Animals | 4 | 2020 | 78931 | 0.05 | Why? |
| Liver Transplantation | 1 | 2017 | 2864 | 0.05 | Why? |
| Biomarkers | 2 | 2021 | 23361 | 0.05 | Why? |
| Inflammation | 2 | 2020 | 13255 | 0.05 | Why? |
| Interferon Regulatory Factor-7 | 1 | 2020 | 234 | 0.05 | Why? |
| Female | 11 | 2021 | 380317 | 0.05 | Why? |
| Male | 10 | 2021 | 367725 | 0.05 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 9335 | 0.05 | Why? |
| Genetic Loci | 1 | 2020 | 439 | 0.05 | Why? |
| Adult | 9 | 2021 | 244371 | 0.05 | Why? |
| Receptor, Interferon alpha-beta | 1 | 2020 | 610 | 0.04 | Why? |
| Raffinose | 1 | 2017 | 5 | 0.04 | Why? |
| Tuberculin Test | 1 | 2018 | 141 | 0.04 | Why? |
| Toll-Like Receptor 3 | 1 | 2020 | 391 | 0.04 | Why? |
| Dioxygenases | 1 | 2017 | 40 | 0.04 | Why? |
| Enterobacteriaceae | 1 | 2021 | 395 | 0.04 | Why? |
| Decidua | 1 | 2016 | 32 | 0.04 | Why? |
| Allopurinol | 1 | 2017 | 59 | 0.04 | Why? |
| Transplantation, Heterologous | 1 | 2017 | 77 | 0.04 | Why? |
| Antigens, CD34 | 1 | 2017 | 125 | 0.04 | Why? |
| DNA, Bacterial | 1 | 2021 | 835 | 0.04 | Why? |
| HLA-G Antigens | 1 | 2016 | 48 | 0.04 | Why? |
| CX3C Chemokine Receptor 1 | 1 | 2015 | 21 | 0.04 | Why? |
| Interferon-gamma Release Tests | 1 | 2018 | 253 | 0.04 | Why? |
| Bacteriophages | 1 | 2019 | 268 | 0.04 | Why? |
| Aged | 6 | 2021 | 215776 | 0.04 | Why? |
| Receptors, Chemokine | 1 | 2015 | 56 | 0.04 | Why? |
| Cervix Uteri | 1 | 2016 | 146 | 0.04 | Why? |
| Middle Aged | 7 | 2021 | 270681 | 0.04 | Why? |
| Reperfusion Injury | 1 | 2017 | 178 | 0.04 | Why? |
| Glutathione | 1 | 2017 | 280 | 0.04 | Why? |
| France | 2 | 2021 | 12074 | 0.04 | Why? |
| Trophoblasts | 1 | 2016 | 237 | 0.03 | Why? |
| Paris | 1 | 2018 | 1287 | 0.03 | Why? |
| Lipopolysaccharide Receptors | 1 | 2016 | 357 | 0.03 | Why? |
| Receptors, CCR5 | 1 | 2015 | 186 | 0.03 | Why? |
| Bone Marrow Transplantation | 1 | 2017 | 343 | 0.03 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.03 | Why? |
| Molecular Biology | 1 | 2015 | 139 | 0.03 | Why? |
| Protein Binding | 2 | 2021 | 11430 | 0.03 | Why? |
| Interferon-alpha | 1 | 2021 | 1442 | 0.03 | Why? |
| Adenosine | 1 | 2017 | 509 | 0.03 | Why? |
| Immunophenotyping | 1 | 2017 | 1290 | 0.03 | Why? |
| Cell Line, Tumor | 1 | 2021 | 3608 | 0.03 | Why? |
| Histocompatibility Antigens Class I | 1 | 2016 | 624 | 0.03 | Why? |
| Lymphocyte Activation | 1 | 2021 | 2742 | 0.03 | Why? |
| Asymptomatic Infections | 2 | 2020 | 7218 | 0.03 | Why? |
| Vaccination | 1 | 2017 | 19050 | 0.03 | Why? |
| Cell Differentiation | 1 | 2017 | 1338 | 0.03 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.03 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.03 | Why? |
| Epitopes, T-Lymphocyte | 1 | 2021 | 2262 | 0.03 | Why? |
| Immunologic Memory | 1 | 2021 | 3362 | 0.02 | Why? |
| Mice, Inbred BALB C | 1 | 2019 | 5814 | 0.02 | Why? |
| Binding Sites | 1 | 2021 | 6201 | 0.02 | Why? |
| Insulin | 1 | 2017 | 1316 | 0.02 | Why? |
| Infant | 2 | 2021 | 30274 | 0.02 | Why? |
| Critical Illness | 2 | 2021 | 17281 | 0.02 | Why? |
| Survival Rate | 1 | 2021 | 9206 | 0.02 | Why? |
| Peptides | 1 | 2019 | 2513 | 0.02 | Why? |
| Child, Preschool | 2 | 2021 | 36283 | 0.02 | Why? |
| Killer Cells, Natural | 1 | 2016 | 2093 | 0.02 | Why? |
| Gene Expression | 1 | 2017 | 3332 | 0.02 | Why? |
| Multiple Organ Failure | 1 | 2017 | 1724 | 0.02 | Why? |
| Adolescent | 3 | 2021 | 86841 | 0.02 | Why? |
| Young Adult | 3 | 2021 | 93724 | 0.02 | Why? |
| Genetic Predisposition to Disease | 1 | 2020 | 4027 | 0.02 | Why? |
| Neutralization Tests | 1 | 2019 | 6698 | 0.02 | Why? |
| Macrophages | 1 | 2017 | 2784 | 0.02 | Why? |
| Models, Molecular | 1 | 2019 | 7616 | 0.02 | Why? |
| Monocytes | 1 | 2017 | 2978 | 0.02 | Why? |
| Receptors, Virus | 1 | 2021 | 5659 | 0.02 | Why? |
| Prospective Studies | 2 | 2021 | 43301 | 0.02 | Why? |
| HIV-1 | 1 | 2019 | 3365 | 0.02 | Why? |
| Molecular Docking Simulation | 1 | 2019 | 6902 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 7868 | 0.02 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.01 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Child | 2 | 2021 | 70012 | 0.01 | Why? |
| Infant, Newborn | 1 | 2021 | 23105 | 0.01 | Why? |
| Cell Line | 1 | 2015 | 12040 | 0.01 | Why? |
| Postoperative Complications | 1 | 2017 | 5861 | 0.01 | Why? |
| Prognosis | 1 | 2021 | 32490 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2018 | 22971 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| Mutation | 1 | 2017 | 12376 | 0.01 | Why? |
| Pregnancy | 1 | 2016 | 23879 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.01 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.01 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.00 | Why? |
Gorochov's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(169)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(422)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_